{"entity":{"type":"insider","cik":"0001464547","url":"/insider/0001464547","json_url":"/insider/0001464547.json","name":"Sardesai Niranjan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2012-05-17","last":"2016-08-30","span_basis":"filed_date"},"name_variants":[{"name":"Sardesai Niranjan","source":"filing","n_filings":5,"first_seen":"2012-05-17","last_seen":"2016-08-30"}],"transactions":[{"id":2059478,"accession":"0001055726-16-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001055726-16-000064","line_url":"/filing/0001055726-16-000064#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464547","owner_name":"Sardesai Niranjan","owner_display_name":"Sardesai Niranjan","owner_url":"/insider/0001464547","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21800.0,"shares_display":"21,800","price_per_share":9.2997,"price_display":"9.30","price_state":"stated","total_value":202733.46,"total_display":"202,733.46","total_whole":"202,733","shares_owned_after":48434.0,"shares_owned_after_display":"48,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-29","filed_date":"2016-08-30","scope":"insider"},{"id":8630017,"accession":"0001055726-15-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001055726-15-000012","line_url":"/filing/0001055726-15-000012#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464547","owner_name":"Sardesai Niranjan","owner_display_name":"Sardesai Niranjan","owner_url":"/insider/0001464547","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":22000.0,"total_display":"22,000.00","total_whole":"22,000","shares_owned_after":32000.0,"shares_owned_after_display":"32,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-30","filed_date":"2015-09-30","scope":"insider"},{"id":6904038,"accession":"0001179110-14-012758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-012758","line_url":"/filing/0001179110-14-012758#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464547","owner_name":"Sardesai Niranjan","owner_display_name":"Sardesai Niranjan","owner_url":"/insider/0001464547","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2550.0,"shares_display":"2,550","price_per_share":8.7,"price_display":"8.70","price_state":"stated","total_value":22185.0,"total_display":"22,185.00","total_whole":"22,185","shares_owned_after":28000.0,"shares_owned_after_display":"28,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-12","scope":"insider"},{"id":5550450,"accession":"0001179110-13-005633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-005633","line_url":"/filing/0001179110-13-005633#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464547","owner_name":"Sardesai Niranjan","owner_display_name":"Sardesai Niranjan","owner_url":"/insider/0001464547","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.5331,"price_display":"0.53","price_state":"stated","total_value":13327.5,"total_display":"13,327.50","total_whole":"13,328","shares_owned_after":101800.0,"shares_owned_after_display":"101,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-20","filed_date":"2013-03-22","scope":"insider"},{"id":3450813,"accession":"0001179110-12-008553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-008553","line_url":"/filing/0001179110-12-008553#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001464547","owner_name":"Sardesai Niranjan","owner_display_name":"Sardesai Niranjan","owner_url":"/insider/0001464547","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":4500.0,"total_display":"4,500.00","total_whole":"4,500","shares_owned_after":76800.0,"shares_owned_after_display":"76,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-16","filed_date":"2012-05-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001055726","name":"INOVIO PHARMACEUTICALS, INC.","url":"/issuer/0001055726","role":"Officer (Chief Operating Officer)","n_filings":5,"first_seen":"2012-05-17","last_seen":"2016-08-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001464547","retrieved_at":"2026-08-22T15:01:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}